Bio Path reported $261K in Debt for its fiscal quarter ending in March of 2025.





Debt Change Date
Alterity Therapeutics Limited AUD 210.39K 120.67K Jun/2023
Baxter International USD 9.69B 93M Mar/2026
Bio Path USD 261K 261K Mar/2025
Cipla INR 6.14B 1.76B Mar/2026
Clal Biotechnology ILS 35.76M 28.27M Dec/2023
Compugen USD 2.93M 14K Mar/2026
CSL USD 11.96B 219M Dec/2024
Grifols EUR 9.23B 626.05M Dec/2024
Karyopharm Therapeutics USD 299.23M 35.14M Dec/2025